Literature DB >> 2804357

Food iron absorption in idiopathic hemochromatosis.

S R Lynch1, B S Skikne, J D Cook.   

Abstract

The relationship between iron status and food iron absorption was evaluated in 75 normal volunteers, 15 patients with idiopathic hemochromatosis, and 22 heterozygotes by using double extrinsic radioiron tags to label independently the nonheme and heme iron components of a hamburger meal. In normal subjects, absorption from each of these pools was inversely correlated with storage iron, as measured by the serum ferritin concentration. In patients with hemochromatosis, absorption of both forms of iron was far greater than would be predicted from the relationship between absorption and serum ferritin observed in normal volunteers. Nevertheless, there was still a modest but statistically significant reduction in absorption of nonheme iron with increasing serum ferritin. This relationship could not be demonstrated in the case of heme iron absorption. In heterozygotes, nonheme iron absorption from a hamburger meal containing no supplementary iron did not differ significantly from that observed in normal volunteers. However, when this meal was both modified to promote bioavailability and supplemented with iron, absorption of nonheme iron was significantly elevated. These studies confirm the presence of excessive nonheme iron absorption even from unfortified meals in patients with idiopathic hemochromatosis and suggest in addition that they are particularly susceptible to iron loading from diets containing a high proportion of heme iron. Impaired regulation of nonheme iron absorption was also observed in heterozygous individuals, but a statistically significant abnormality was demonstrable only when the test meal contained a large highly bioavailable iron supplement.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2804357

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Dietary iron intake and serum ferritin concentration in 213 patients homozygous for the HFEC282Y hemochromatosis mutation.

Authors:  Victor R Gordeuk; Laura Lovato; James Barton; Mara Vitolins; Gordon McLaren; Ronald Acton; Christine McLaren; Emily Harris; Mark Speechley; John H Eckfeldt; Sharmin Diaz; Phyliss Sholinsky; Paul Adams
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

2.  Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis.

Authors:  D A Rhodes; R Raha-Chowdhury; T M Cox; J Trowsdale
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

Review 3.  Molecular insights into the pathogenesis of hereditary haemochromatosis.

Authors:  A Pietrangelo
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

4.  Patient screening for cardiac hemochromatosis, echocardiography or MRI?

Authors:  L H B Baur
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-16       Impact factor: 2.357

5.  Effect of SNPs on iron metabolism.

Authors:  S J Fairweather-Tait; L Harvey; A-L M Heath; M Roe
Journal:  Genes Nutr       Date:  2007-10       Impact factor: 5.523

6.  BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice.

Authors:  Elena Corradini; Paul J Schmidt; Delphine Meynard; Cinzia Garuti; Giuliana Montosi; Shanzhuo Chen; Slobodan Vukicevic; Antonello Pietrangelo; Herbert Y Lin; Jodie L Babitt
Journal:  Gastroenterology       Date:  2010-08-01       Impact factor: 22.682

7.  Clinical penetrance of C282Y homozygous HFE haemochromatosis.

Authors:  Enrico Rossi; Gary P Jeffrey
Journal:  Clin Biochem Rev       Date:  2004-08

8.  Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis.

Authors:  T Kelleher; E Ryan; S Barrett; M Sweeney; V Byrnes; C O'Keane; J Crowe
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 9.  Iron overload cardiomyopathies: new insights into an old disease.

Authors:  P Liu; N Olivieri
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

10.  Early detection of iron overload in the heart: a key role for MRI!

Authors:  Leo H B Baur
Journal:  Int J Cardiovasc Imaging       Date:  2009-11-24       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.